Talking Precision Medicine Ryan Fukushima | Reinventing diagnostics: The superpower of not knowing what can’t be done | TPM #43
Feb 26, 2025
Ryan Fukushima is the COO of Tempus AI and CEO of Pathos AI, a trailblazer in using real-world data and AI for precision medicine. He discusses the transformative potential of integrated data in personalizing patient care. Ryan highlights innovations in cancer diagnostics, emphasizing a shift from narrow testing to a comprehensive data approach. He explains how AI and biomarkers are redefining treatment decisions, and he envisions a future where AI enhances healthcare, necessitating robust data infrastructure for better outcomes.
AI Snips
Chapters
Transcript
Episode notes
Tempus' Origin
- Ryan Fukushima and Eric Lefkofsky's personal experiences with cancer care motivated them to create Tempus.
- They saw a need for better data connectivity and more comprehensive diagnostics.
Rethinking Diagnostics
- Traditional diagnostic company business models incentivize smaller, not broader tests.
- Tempus built a model that incentivizes comprehensive diagnostics to advance new treatments.
Early Adoption
- Initially, Tempus appeared out of nowhere and faced a cold start challenge with health systems.
- Two health systems took a leap of faith, leading to demonstrable results and wider adoption.